Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Flow Neuroscience AB

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Flow Neuroscience AB

Regulatory records
2
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 2 FDA records to the applicant name Flow Neuroscience AB. It includes 1 original PMA approval. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 8, 2025 to Jul 14, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code JXK appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P230024, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 470 Ramona St., Palo Alto, CA, 94301. Recorded on P230024/S001, decision dated Jul 14, 2026.

Changes described in PMA records

P230024/S001: Flow FL-100

FDA’s recorded scope: approval for minor device design changes, editorial and maintenance updates to existing firmware, server and application documentation, clarification updates to accessory pad specifications, and a minor mechanical design change.

Jul 14, 2026 · Real-Time Process

P230024: Flow FL-100

FDA’s recorded scope: FL-100 is intended for the treatment of moderate to severe major depressive disorder in the current episode, either as monotherapy or as an adjunctive treatment, in patients 18 years and older who are not considered treatment refractory to medication.

Dec 8, 2025

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

  1. Flow FL-100

    P230024/S001 · PMA supplement
  2. Flow FL-100

    P230024 · PMA decision
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.